118 related articles for article (PubMed ID: 21916618)
1. Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: a pilot study.
Trinavarat A; Atchaneeyasakul LO
J Ocul Pharmacol Ther; 2012 Feb; 28(1):53-8. PubMed ID: 21916618
[TBL] [Abstract][Full Text] [Related]
2. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
[TBL] [Abstract][Full Text] [Related]
3. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R
Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732
[TBL] [Abstract][Full Text] [Related]
4. Topical Pharmacologic Interventions Versus Active Control, Placebo, or No Treatment for Epidemic Keratoconjunctivitis: Findings From a Cochrane Systematic Review.
Liu SH; Hawkins BS; Ren M; Ng SM; Leslie L; Han G; Kuo IC
Am J Ophthalmol; 2022 Aug; 240():265-275. PubMed ID: 35331686
[TBL] [Abstract][Full Text] [Related]
5. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA
Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415
[TBL] [Abstract][Full Text] [Related]
6. Can povidone-iodine solution be used safely in a spinal surgery?
Chang FY; Chang MC; Wang ST; Yu WK; Liu CL; Chen TH
Eur Spine J; 2006 Jun; 15(6):1005-14. PubMed ID: 16133077
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with povidone-iodine eye drops in patients with conjunctivitis and keratoconjunctivitis.
Schuhman G; Vidic B
J Hosp Infect; 1985 Mar; 6 Suppl A():173-5. PubMed ID: 2860164
[TBL] [Abstract][Full Text] [Related]
8. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population.
Bekmez S; Eris E
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975
[No Abstract] [Full Text] [Related]
9. Reduction of endophthalmitis rate after cataract surgery with preoperative 5% povidone-iodine.
Trinavarat A; Atchaneeyasakul LO; Nopmaneejumruslers C; Inson K
Dermatology; 2006; 212 Suppl 1():35-40. PubMed ID: 16490973
[TBL] [Abstract][Full Text] [Related]
10. Success of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study.
Whiteside MM; Shorter ES; Margolis MS; Alvi F; Huecker JB; Than TP; Migneco MK; Harthan JS; Morettin CE; Hartwick ATE; Johnson SD; Perera CD; Gordon MO
Optom Vis Sci; 2021 May; 98(5):469-475. PubMed ID: 33973917
[TBL] [Abstract][Full Text] [Related]
11. Ocular surface effects of repeated application of povidone iodine in patients receiving frequent intravitreal injections.
Saedon H; Nosek J; Phillips J; Narendran N; Yang YC
Cutan Ocul Toxicol; 2017 Dec; 36(4):343-346. PubMed ID: 28166657
[TBL] [Abstract][Full Text] [Related]
12. Efficacy comparison between povidone iodine 2.5% and tetracycline 1% in prevention of ophthalmia neonatorum.
David M; Rumelt S; Weintraub Z
Ophthalmology; 2011 Jul; 118(7):1454-8. PubMed ID: 21439642
[TBL] [Abstract][Full Text] [Related]
13. A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis.
Ta CN; Raizman MB; Gross RD; Joshi S; Mallick S; Wang Y; Segal B
Am J Ophthalmol; 2020 Jul; 215():56-65. PubMed ID: 32222367
[TBL] [Abstract][Full Text] [Related]
14. No risk of surgical site infections from residual bacteria after disinfection with povidone-iodine-alcohol in 1014 cases: a prospective observational study.
Tschudin-Sutter S; Frei R; Egli-Gany D; Eckstein F; Valderrabano V; Dangel M; Battegay M; Widmer AF
Ann Surg; 2012 Mar; 255(3):565-9. PubMed ID: 22330031
[TBL] [Abstract][Full Text] [Related]
15. Patch testing to exclude allergic contact dermatitis caused by povidone-iodine.
Kozuka T
Dermatology; 2002; 204 Suppl 1():96-8. PubMed ID: 12011530
[TBL] [Abstract][Full Text] [Related]
16. Effect of oropharyngeal povidone-iodine preventive oral care on ventilator-associated pneumonia in severely brain-injured or cerebral hemorrhage patients: a multicenter, randomized controlled trial.
Seguin P; Laviolle B; Dahyot-Fizelier C; Dumont R; Veber B; Gergaud S; Asehnoune K; Mimoz O; Donnio PY; Bellissant E; Malledant Y; ;
Crit Care Med; 2014 Jan; 42(1):1-8. PubMed ID: 24105456
[TBL] [Abstract][Full Text] [Related]
17. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac.
Halachmi-Eyal O; Lang Y; Keness Y; Miron D
J Cataract Refract Surg; 2009 Dec; 35(12):2109-14. PubMed ID: 19969216
[TBL] [Abstract][Full Text] [Related]
18. Povidone iodine in the treatment of adenoviral conjunctivitis in infants.
Özen Tunay Z; Ozdemir O; Petricli IS
Cutan Ocul Toxicol; 2015 Mar; 34(1):12-5. PubMed ID: 24678746
[TBL] [Abstract][Full Text] [Related]
19. A randomised trial of povidone-iodine to reduce visual impairment from corneal ulcers in rural Nepal.
Katz J; Khatry SK; Thapa MD; Schein OD; Kimbrough Pradhan E; LeClerq SC; West KP
Br J Ophthalmol; 2004 Dec; 88(12):1487-92. PubMed ID: 15548795
[TBL] [Abstract][Full Text] [Related]
20. Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. A randomised, double-blind, active-controlled, multicentric clinical study.
Petersen EE; Weissenbacher ER; Hengst P; Spitzbart H; Weise W; Wolff F; Dreher E; Ernst U; Della Casa V; Pohlig G; Graf F; Kaiser RR
Arzneimittelforschung; 2002; 52(9):706-15. PubMed ID: 12404887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
